Clinical Trials Directory

Trials / Unknown

UnknownNCT04598087

Prehabilitation and Recovery After Head and Neck Cancer Surgery

Multiphasic Prehabilitation in Patients Undergoing Surgery for Head and Neck Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Implementing a multiphasic, multimodal prehabilitation intervention for people undergoing surgery with free flap reconstruction for the treatment of head and neck cancer.

Detailed description

BACKGROUND: Head and neck cancer (HNC) is the 7th most common cancer worldwide, and treatment often involves surgery. HNC surgery is intensive, complications are common, and quality of life (QOL) is negatively impacted. Support must be expanded to not only help patients survive HNC but to recover faster and live well following surgery. Prehabilitation, or optimizing a patient's condition before surgery, is a key opportunity to integrate supportive care early in the clinical care pathway for this underserved patient group. RESEARCH DESIGN AND METHODS: Using a mixed-methods approach, the aims of this hybrid implementation-effectiveness study are to (i) implement a multiphasic exercise prehabilitation program for HNC patients in a real-world setting and describe factors influencing implementation across the phases; (ii) determine the safety and tolerability of a multiphasic exercise prehabilitation program for HNC patients; (iii) explore the potential benefits of a multiphasic exercise prehabilitation program for HNC patients, and (iv) build a systematic screening and referral pathway into exercise oncology resources post-operatively. Outcomes are detailed below and include patient-reported outcomes, physical function, mobility (step count) and hospital length of stay.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrehabilitationThe multi-phasic prehabilitation intervention involves three phases: Phase 1: Before surgery (typically \~25 days); Phase 2: The in-hospital phase (typically 10-14 days); Phase 3: Discharge to 6-weeks after surgery.

Timeline

Start date
2022-02-09
Primary completion
2023-12-31
Completion
2024-12-31
First posted
2020-10-22
Last updated
2022-03-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04598087. Inclusion in this directory is not an endorsement.